Rhenman & Partners Asset Management AB Has $12.52 Million Stock Position in Cytokinetics, Incorporated (NASDAQ:CYTK)

Rhenman & Partners Asset Management AB lowered its holdings in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 25.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 149,912 shares of the biopharmaceutical company’s stock after selling 50,088 shares during the quarter. Rhenman & Partners Asset […]

Related Keywords

,Fady Ibraham Malik ,Robert Wong ,Raymond James ,Barclays ,Cytokinetics Incorporated ,Needham Company ,First Turn Management ,Charles Schwab Investment Management Inc ,Norges Bank ,Vanguard Group Inc ,Securities Exchange Commission ,Partners Asset Management ,Free Report ,Turn Management ,Schwab Investment Management ,Stock Down ,Get Free Report ,Ibraham Malik ,Cytokinetics Daily ,